Association of opioid use with response to immune checkpoint inhibitors.

被引：0
|
作者：
Weinfeld, Michael
Wang, Heidy
Liu, Li C.
Pasquinelli, Mary
Huber, Michael
Feldman, Lawrence Eric
Weinberg, Frank
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[3] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
[4] Jesse Brown VA Med Ctr, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14595
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of antibiotic use on response to treatment with immune checkpoint inhibitors.
    Khan, Uqba
    Pena, Cristian
    Brouwer, Julianna
    Hoffman, Katherine
    Choudhury, Arindam Roy
    Zhang, Chao
    Thakkar, Prashant
    Betel, Doron
    Sarkar, Sandipto
    Sonnenberg, Gregory
    Saxena, Ashish
    Shah, Manish A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [2] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Immune checkpoint inhibitors. A breakthrough in cancer therapy
    Cardenas-Oyarzo, Areli M.
    Bocchieri-Oyarce, Pamela A.
    Mendez-Laport, Cristian R.
    Zolezzi, Juan M.
    Rios, Juvenal A.
    REVISTA MEDICA DE CHILE, 2022, 150 (01) : 93 - 99
  • [4] Infections in patients receiving immune checkpoint inhibitors.
    Sae-Tia, Sutthichai
    Naidoo, Jarushka
    Mehta, Seema
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [5] Evaluation of tolerability and reactions of immune checkpoint inhibitors.
    Sever, Ozlem Nuray
    Sonmez, Ozlem
    Demir, Osman Gokhan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Association of immune-related adverse effects and survival in responders treated with immune checkpoint inhibitors.
    Kapoor, Akhil
    Noronha, Vanita
    Patil, Vijay Maruti
    Joshi, Amit
    Menon, Nandini Sharrel
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.
    Sarfaty, Michal
    Desjardins, Christopher A.
    Giardina, Paul
    Bardhan, Kankana
    Pandian, Swarna
    Halley, Keith
    Halvorsen, Elizabeth M.
    Callahan, Margaret K.
    Postow, Michael A.
    Lee, Chung-Han
    Kotecha, Ritesh
    Kashani, Daniel
    Ratna, Neha
    Regazzi, Ashley Marie
    Henn, Matthew R.
    Hellmann, Matthew D.
    Iyer, Gopa
    Ford, Christopher B.
    Peled, Jonathan U.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Inhaled corticosteroid use and risk of pneumonitis in patients treated with immune checkpoint inhibitors.
    Li, Mingjia
    Spakowicz, Daniel
    Zhao, Songzhu
    Patel, Sandip H.
    Johns, Andrew
    Grogan, Madison
    Miah, Abdul
    Husain, Marium
    He, Kai
    Bertino, Erin Marie
    Shields, Peter G.
    Wei, Lai
    Carbone, David Paul
    Otterson, Gregory Alan
    Presley, Carolyn J.
    Owen, Dwight Hall
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Immune checkpoint inhibitors. Novel treatment approaches in oncology
    Scheich, Sebastian
    Sebastian, Martin
    ONKOLOGE, 2017, 23 (07): : 575 - 582
  • [10] Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.
    Papaiakovou, Evangelos Eleutherakis
    Kastritis, Efstathios
    Zagouri, Flora
    Grapsa, Dimitra
    Ntanassis-Stathopoulos, Ioannis
    Stefanou, Dimitra
    Evangelou, Georgios
    Kotteas, Ilias
    Dimopoulos, Meletios A.
    Syrigos, Konstantinos
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345